3D ENDOSCOPIC MITRAL VALVE REPLACEMENT WITH BIOPROSTHESIS IN ELDERLY PATIENTS AT CARDIOVASCULAR CENTER, E HOSPITAL
Main Article Content
Abstract
Objective: To summarize the initial experiences and evaluate the early results of applying 3D endoscopic surgery for biological mitral valve replacement in the elderly.
Subjects and methods: The study was conducted by cross-sectional method, retrospective data including all patients ≥ 60 years old, who underwent 3D endoscopic surgery for biological mitral valve replacement at the Cardiovascular Center of Hospital E between January 2021 and December 2023.
Results: The study included 67 patients, with an average age of 65.6 ± 4.8 years, male/female ratio is 2/1. Before surgery: 74.6% NYHA 3-4 heart failure; 49.3% arrhythmia; 10.5% EF below 50%. Extracorporeal circulation time 155.3 ± 30.7 minutes; aortic clamping time 114.8 ± 26.6 minutes. 29.9% of patients underwent left atrial appendage suturing; 1.5% tricuspid valve repair. After surgery, prolonged mechanical ventilation time (over 2 days) 20.9%; intensive care unit stay 2.9 ± 1.7 days; hospital stay 13.3 ± 5.1 days. Complications included: ventricular rupture (3.0%), in-hospital death (3.0%), reoperation due to bleeding (4.5%), renal failure (3.0%), and cerebral infarction (1.5%).
Conclusions: 3D endoscopic surgery for bioprosthetic mitral valve replacement has been routinely performed at E Hospital with positive results and needs further research on a larger number of patients over a longer period of time.
Article Details
Keywords
Mitral valve, mitral bioprothesis, minimally invasive cardiac surgery, 3D endoscopic surgery.
References
[2] Pausch J, Bhadra O.D et al. Early outcome of endoscopic mitral valve surgery in elderly patients: a high-volume single center experience. Front Cardiovasc Med, 2023, 10: 1182752. doi: 10.3389/fcvm.2023.1182752
[3] Francica A, Barbero C et al. Minimally invasive mitral valve surgery in elderly patients: results from a multicenter study. J Clin Med, 2024, 13 (21): 6320. doi: 10.3390/jcm13216320
[4] Olsthoorn J.R, Heuts S, Houterman S, Maessen J.G, Sardari Nia P. Effect of minimally invasive mitral valve surgery compared to sternotomy on short- and long-term outcomes: a retrospective multicentre interventional cohort study based on Netherlands Heart Registration. Eur J Cardiothorac Surg, 2022, 61 (5): 1099-1106. doi: 10.1093/ejcts/ezac059
[5] Nguyễn Bá Phong. Đánh giá kết quả phẫu thuật thay van hai lá sinh học SJM Biocor tại Trung tâm Tim mạch, Bệnh viện E. Luận văn thạc sĩ y học, Trường Đại học Y Hà Nội, 2015.
[6] Mạc Thế Trường. Đánh giá kết quả thay van hai lá bằng van nhân tạo sinh học tại Bệnh viện Hữu nghị Việt Đức. Luận văn thạc sĩ y học, Trường Đại học Y Hà Nội, 2017.
[7] Phạm Thành Đạt. Đánh giá kết quả sớm phẫu thuật thay van hai lá ít xâm lấn có nội soi hỗ trợ tại Trung tâm Tim mạch, Bệnh viện E, Luận văn thạc sĩ y học, Trường Đại học Y Hà Nội, 2015.
[8] Alsheebani S, Goubran D et al. Contemporary review of minimally invasive mitral valve surgery: Current Considerations and Innovations. J Cardiovasc Dev Dis, 2024, 11 (12): 404. doi: 10.3390/jcdd11120404
[9] Võ Tuấn Anh. Nghiên cứu hiệu quả của phẫu thuật van hai lá ít xâm lấn qua đường mở ngực phải. Luận án tiến sĩ y học, Đại học Y Dược thành phố Hồ Chí Minh, 2020.
[10] Zhai Z, Wei L et al. Minimally invasive mitral valve replacement is a safe and effective surgery for patients with rheumatic valve disease: a retrospective study. Medicine (Baltimore), 2017, 96 (24): e7193. doi: 10.1097/MD.0000000000007193.
[11] Holzhey D.M, Seeburger J et al. Learning minimally invasive mitral valve surgery: a cumulative sum sequential probability analysis of 3895 operations from a single high-volume center. Circulation, 2013, 128 (5): 483-491. doi: 10.1161/Circulationaha.112.001402
[12] Cheng D.C.H, Martin J et al. Minimally invasive versus conventional open mitral valve surgery: a meta-analysis and systematic review. Innovations (Phila). 2011, 6 (2): 84-103. doi: 10.1097/IMI.0b013e3182167feb.